Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection (vol 14, pg 4819, 2021)

被引：0
|
作者：
LeVee, A.
Lin, C. Y.
Posadas, E.
机构：
来源：
ONCOTARGETS AND THERAPY | 2021年 / 14卷
关键词：
D O I：
10.2147/OTT.S343977
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：5167 / 5167
页数：1
相关论文
共 50 条
  • [1] Clinical Utility of Olaparib in the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Review of Current Evidence and Patient Selection
    LeVee, Alexis
    Lin, Ching Ying
    Posadas, Edwin
    Figlin, Robert
    Bhowmick, Neil A.
    Di Vizio, Dolores
    Ellis, Leigh
    Rosser, Charlos J.
    Freeman, Michael R.
    Theodorescu, Dan
    Freedland, Stephen J.
    Gong, Jun
    ONCOTARGETS AND THERAPY, 2021, 14 : 4819 - 4832
  • [2] Contextualizing Olaparib and Abiraterone in the Current Treatment Landscape for Metastatic Castration-resistant Prostate Cancer
    Fallara, Giuseppe
    Robesti, Daniele
    Raggi, Daniele
    Montorsi, Francesco
    Necchi, Andrea
    Cooperberg, Matthew R.
    Malavaud, Bernard
    Ploussard, Guillaume
    Martini, Alberto
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 52 : 40 - 43
  • [3] Overview of Olaparib as a treatment option for metastatic castration-resistant prostate cancer
    Mourmouris, Panagiotis
    Papatsoris, Athanasios
    Dellis, Athanasios
    Mitsogiannis, Iraklis
    Abou Chakra, Mohamed
    Moussa, Mohamad
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (15) : 1955 - 1959
  • [4] Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations
    Patel, Sheel A.
    Hoffman-Censits, Jean
    ONCOTARGETS AND THERAPY, 2017, 10 : 4089 - 4098
  • [5] Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence
    Livi, Lorenzo
    Detti, Beatrice
    Francolini, Giulio
    Terziani, Francesca
    Triggiani, Luca
    D'Angelillo, Rolando M.
    Ingrosso, Gianluca
    TUMORI JOURNAL, 2019, 105 (04): : 277 - 281
  • [6] International experience of using olaparib for metastatic castration-resistant prostate cancer: literature review
    Matveev, V. B.
    Khalmurzaev, O. A.
    Evsyukova, O., I
    ONKOUROLOGIYA, 2020, 16 (04): : 197 - 206
  • [7] Acute Myeloid Leukemia After Olaparib Treatment in Metastatic Castration-Resistant Prostate Cancer
    Zhu, Jason
    Tucker, Matthew
    Wang, Endi
    Grossman, Joel S.
    Armstrong, Andrew J.
    George, Daniel J.
    Zhang, Tian
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E1137 - E1141
  • [8] Castration-resistant metastatic prostate cancer: current status and treatment possibilities
    Joan Carles
    Daniel Castellano
    Miguel Ángel Climent
    Pablo Maroto
    Rafael Medina
    Antonio Alcaraz
    Clinical and Translational Oncology, 2012, 14 : 169 - 176
  • [9] Castration-resistant metastatic prostate cancer: current status and treatment possibilities
    Carles, Joan
    Castellano, Daniel
    Angel Climent, Miguel
    Maroto, Pablo
    Medina, Rafael
    Alcaraz, Antonio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (03): : 169 - 176
  • [10] Current and emerging treatment modalities for metastatic castration-resistant prostate cancer
    Bracarda, Sergio
    Logothetis, Christopher
    Sternberg, Cora N.
    Oudard, Stephane
    BJU INTERNATIONAL, 2011, 107 : 13 - 20
12345